Elevated Plasma Asymmetric Dimethylarginine As A Marker of Cardiovascular Morbidity in Early Diabetic Nephropathy in Type 1 Diabetes

Diabetes Care

Volumn 27, Issue 3, 2004, Pages 765-769

  Tarnow, Lise ^a   Hovind, Peter ^a   Teerlink, Tom ^b   Stehouwer, Coen D A ^b   Parving, Hans Henrik ^a,c  

^a STENO DIABETES CENTER   (Denmark)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

N(G),N(G) DIMETHYLARGININE;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; FEMALE; HEART INFARCTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; STROKE;

ADULT; ARGININE; BIOLOGICAL MARKERS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CREATININE; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; MORBIDITY; NITRIC OXIDE SYNTHASE;

EID: 1442299806     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.27.3.765     Document Type: Article

References (23)

1. Chan NN, Vallance P, Colhoun HM: Nitric oxide and vascular responses in type 1 diabetes. Diabetologia 43:137-147, 2000
2. Chan NN, Chan JCN: Asymmetric dimethylarginine (ADMA): a potential link between endothelial dysfunction and cardiovascular diseases in insulin resistance syndrome? Diabetologia 45:1609-1616, 2002
3. Vallance P, Leone A, Calver A, Collier J, Moncada S: Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339:572-575, 1992
4. MacAllister RJ, Rambausek MH, Vallance P, Williams D, Hoffmann KH, Ritz E: Concentration of dimethyl-L-arginine in the plasma of patients with end-stage renal failure. Nephrol Dial Transplant 11:2449-2452, 1996
5. Marescau B, Nagels G, Possimiers I, De Broe ME, Becaus I, Billiouw J-M, Lornoy W, De Deyn PP: Guanidino compounds in serum and urine if nondialyzed patients with chronic renal insufficiency. Metabolism 46:1024-1031, 1997
6. Kielstein JT, Böger RH, Bode-Böger SM, Schäffer J, Barbey M, Koch KM, Frölich JC: Asymmetric dimethylarginine plasma concentration differ in patients with end-stage renal disease: relationship to treatment method and atherosclerotic disease. J Am Soc Nephrol 10:594-600, 1999
7. Zoccali C, Bode-Böger SM, Mallamaci F, Benedetto FA, Tripepi G, Malatino LS, Cataliotti A, Bellanuova I, Fermo I, Frölich JC, Böger RH: Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. Lancet 358:2113-2117, 2001
8. Kielstein JT, Böger RH, Bode-Böger SM, Frölich JC, Haller H, Ritz E: Marked increase of asymmetrical dimethylarginine in patients with incipient primary chronic renal disease. J Am Soc Nephrol 13:170-176, 2002
9. Tojo A, Welch WJ, Bremer V, Kimoto M, Kimura K, Omata M, Ogawa T, Vallance P, Wilcox CS: Colocalization of dimethylating enzymes and NOS and functional effects of methylarginines in rat kidney. Kidney Int 52:1593-1601, 1997
10. Lin KY, Asagami T, Tsao PS, Adimoolam S, Kimoto M, Tsuji H, Reaven GM, Cooke JP: Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase. Circulation 106:987-992, 2002
11. Abbassi F, Asagami T, Cooke JP, Lamendola C, McLaughlin T, Reaven GM, Stühlinger MC, Tsao PS: Plasma Concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus. Am J Cardiol 88:1201-1203, 2001
12. Stühlinger MC, Abbassi F, Chu JW, Lamendola C, McLaughlin TL, Cooke JP, Reaven GM, Tsao PS: Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. JAMA 287:1420-1426, 2002
13. Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen BV, Lecerf L, Poirier O, Danilov S, Boelskifte S, Borch-Johnsen K, Parving H-H: Insertion/deletion polymorphism in the angiotensin-I-converting enzyme gene is associated with coronary heart disease in IDDM patients with diabetic nephropathy. Diabetologia 38:798-803, 1995
14. Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen BV, Lecerf L, Poirier O, Danilov S, Parving H-H: Lack of relationship between an insertion/deletion polymorphism in the angiotensin-I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes 44:489-494, 1995
15. Parving H-H, Andersen AR, Smidt UM, Svendsen PA: Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet i:1175-1179, 1983
16. Feldt-Rasmussen B, Dinesen B, Deckert M: Enzyme immunoassay: an improved determination of urinary albumin in diabetics with incipient nephropathy. Scand J Clin Lab Invest 45:539-544, 1985
17. Bröchner-Mortensen J, Rödbro P: Selection of routine method for determination of glomerular filtration rate in adult patients. Scand J Clin Lab Invest 36:35-45, 1976
18. Teerlink T, Nijveldt RJ, de Jong S, van Leeuwen PAM: Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography. Anal Biochem 303:131-137, 2002
19. Jensen T, Feldt-Rasmussen B, Bjerre-Knudsen J, Deckert T: Features of endothelial dysfunction in early diabetic nephropathy. Lancet i:461-463, 1989
20. Chan NN, Vallance P, Colhoun HM: Endothelium-dependent and -independent vascular dysfunction in type 1 diabetes: role of conventional risk factors, sex, and glycemic control. Arterioscler Thromb Vasc Biol 23:1048-1054, 2003
21. Valkonen V-P, Pälvä H, Salonen JT, Lakka TA, Lehtimäki TJ, Laakso J, Laaksonen R: Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine. Lancet 358:2127-2128, 2001
22. Zoccali C, Benedetto FA, Maas R, Mallamaci F, Tripepi G, Malatino LS, Böger RH: Asymmetric dimethylarginine, C-reactive protein, and carotid intima-media thickness in end-stage renal disease. J Am Soc Nephrol 13:490-496, 2002
23. Kielstein JT, Bode-Böger SM, Frölich JC, Ritz E, Haller H, Fliser D: Asymmetric dimethylarginine, blood pressure, and renal perfusion in elderly subjects. Circulation 107:1891-1895, 2003